StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report released on Friday. The firm issued a hold rating on the software maker’s stock.
Veradigm Stock Performance
Shares of NASDAQ MDRX opened at $9.45 on Friday. The stock’s 50 day moving average price is $10.01 and its two-hundred day moving average price is $9.73. Veradigm has a 52-week low of $5.01 and a 52-week high of $11.80.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- Low PE Growth Stocks: Unlocking Investment Opportunities
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- Trading Stocks: RSI and Why it’s Useful
- How AI Implementation Could Help MongoDB Roar Back in 2025
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
